Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stuttgart - Delayed Quote EUR

Seres Therapeutics Inc (1S9.SG)

Compare
0.5872
-0.0360
(-5.78%)
At close: April 4 at 9:57:21 PM GMT+2
Loading Chart for 1S9.SG
  • Previous Close 0.6232
  • Open 0.6032
  • Bid 0.6184 x 100000
  • Ask 0.6340 x 100000
  • Day's Range 0.5864 - 0.6092
  • 52 Week Range 0.4971 - 1.3500
  • Volume 0
  • Avg. Volume 244
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1S9.SG

View More

Performance Overview: 1S9.SG

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1S9.SG
28.96%
S&P 500 (^GSPC)
13.73%

1-Year Return

1S9.SG
5.35%
S&P 500 (^GSPC)
1.42%

3-Year Return

1S9.SG
91.46%
S&P 500 (^GSPC)
10.72%

5-Year Return

1S9.SG
79.75%
S&P 500 (^GSPC)
103.89%

Compare To: 1S9.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1S9.SG

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    109.94M

  • Enterprise Value

    165.74M

  • Trailing P/E

    --

  • Forward P/E

    1.54

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    8.60

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1S9.SG

View More

Company Insights: 1S9.SG

Research Reports: 1S9.SG

View More